A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer.
Journal Information
Full Title: Int J Cancer
Abbreviation: Int J Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST Joel M. Palefsky received grant support, SAB, and speaker's fee from Merck, and acted as a consultant for Antiva Biosciences, Virion Biotechnologies and Virion Therapeutics. Finally, he has stock options in Virion Therapeutics. Susanne K. Kjaer previously received speaker's fee from Merck, and a research grant through her institution from Merck. All other authors report no conflicts of interest."
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025